Spain Mice Model Market (2025-2030)
The Spain Mice Model Market was valued at $22 Million in 2025 and projected to reach to $31.7 Million by 2030, representing a compound annual growth rate of 7.5%. Spain's mice model market is experiencing steady growth fueled by increased investment in biomedical research and pharmaceutical development.
Spain Mice Model Market Trends and Insights
- This growth trajectory reflects Spain's strengthening position in preclinical research and biomedical innovation within the European healthcare landscape.
- Spain's investment in research infrastructure and pharmaceutical development has positioned the country as an emerging hub for laboratory animal models, supporting both domestic and international research initiatives. The expansion of Spain's mice model market is driven by increased funding for life sciences research, growing collaborations between academic institutions and pharmaceutical companies, and Spain's commitment to advancing drug discovery and development.
- Between 2025 and 2030, Spain is expected to see sustained demand for high-quality mice models as regulatory requirements and research complexity continue to evolve.
- Spain's market growth, while moderate compared to global trends, reflects the country's strategic focus on precision medicine and translational research capabilities..
Key Market Statistics
- CAGR (2025-2030) 7.5% CAGR
- Market Size, 2025 ~USD 22 Million
- Forecast, 2030 ~USD 31.7 Million
- Country Spain
Spain Mice Model Market Overview
Market Valuation Growth :
Spain's mice model market is valued at $22.0 million in 2025 and is projected to reach $31.7 million by 2030, demonstrating robust expansion in the preclinical research sector.
Strong CAGR Performance :
With a 7.5% CAGR through 2030, Spain's market growth outpaces many European counterparts, driven by increased pharmaceutical R&D investments and biomedical innovation initiatives.
Research Infrastructure Development :
Spain's strengthening research infrastructure and government support for life sciences have positioned the country as a key hub for preclinical studies and drug development in Europe.
Pharmaceutical Industry Expansion :
Growing pharmaceutical and biotechnology sectors in Spain are driving demand for advanced mice models, supporting both domestic and international clinical research programs.
Spain Mice Model Market Dynamics
- The country's commitment to strengthening research infrastructure and supporting life sciences innovation has created favorable conditions for market expansion.
- Spanish research institutions and pharmaceutical companies are increasingly adopting advanced mice models for preclinical testing, aligning with European regulatory standards and global research practices. Looking ahead, Spain's market is expected to benefit from continued government funding for research initiatives, collaboration with international biotech firms, and the expansion of contract research organizations (CROs).
- The 7.5% CAGR reflects Spain's growing importance in the European preclinical research landscape, with opportunities emerging from personalized medicine development and translational research programs..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Spain's mice model market is valued at $22.0 million in 2025 and will reach $31.7 million by 2030, growing at 7.5% CAGR.
- Spain's research infrastructure investments and pharmaceutical collaborations are key drivers of market expansion through 2030.
- Spain's market growth is supported by increased regulatory requirements and demand for preclinical research models in drug development.
- Spain's position within Europe positions it as a secondary but growing hub for laboratory animal model supply and research services.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
Spain Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Pharmaceutical Companies : Spanish and international pharma firms need market data to plan preclinical research investments, optimize R&D budgets, and identify partnership opportunities in Spain's growing biomedical sector.
- Contract Research Organizations (CROs) : CROs operating in Spain require detailed market insights to assess demand for mice model services, benchmark pricing, and develop service offerings aligned with local research needs.
- Research Institutions & Universities : Spanish research centers and academic institutions need market intelligence to secure funding, justify equipment investments, and understand trends in preclinical research methodologies.
- Biotech & Life Sciences Investors : Venture capital and private equity firms targeting Spain's life sciences sector require market data to evaluate investment opportunities and assess growth potential in preclinical research.
- Mice Model Suppliers & Vendors : Suppliers of laboratory mice, breeding services, and related products need Spain-specific market data to identify customer segments, forecast demand, and develop localized sales strategies.
Key Companies in the Spain Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- Spain-Specific Market Sizing : Obtain precise valuation data for Spain's mice model market with detailed 2025-2030 forecasts, enabling accurate budget allocation and investment planning for Spanish operations.
- Competitive Landscape Analysis : Understand Spain's unique market dynamics, key players, and competitive positioning within the broader European preclinical research sector to identify growth opportunities.
- Regulatory & Infrastructure Insights : Gain intelligence on Spain's research regulations, institutional frameworks, and government support mechanisms that drive market growth and influence purchasing decisions.
- Strategic Market Entry Planning : Leverage Spain-focused data to develop targeted market entry strategies, partnership opportunities, and distribution channels for mice model products and services.
- Investment Decision Support : Make informed investment and expansion decisions with comprehensive market intelligence specific to Spain's pharmaceutical, biotech, and research institution sectors.
Frequently asked questions
What is the current size of Spain's mice model market?
Spain's mice model market is valued at $22.0 million in 2025 and is expected to grow to $31.7 million by 2030.
What is the growth rate of Spain's mice model market?
Spain's mice model market is growing at a compound annual growth rate (CAGR) of 7.5% from 2025 to 2030.
What factors are driving growth in Spain's mice model market?
Spain's market growth is driven by increased research funding, pharmaceutical industry collaborations, regulatory requirements for preclinical testing, and Spain's focus on precision medicine and translational research.
How does Spain's mice model market compare to Europe?
Spain represents a growing but secondary market within Europe, with steady expansion driven by domestic research initiatives and international partnerships in the healthcare and pharmaceutical sectors.
What is the forecast for Spain's mice model market by 2030?
Spain's mice model market is projected to reach $31.7 million by 2030, representing a $9.7 million increase from the 2025 baseline of $22.0 million.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- India Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report